Literature DB >> 10449161

Role of CD8alpha+ and CD8alpha- dendritic cells in the induction of primary immune responses in vivo.

R Maldonado-López1, T De Smedt, B Pajak, C Heirman, K Thielemans, O Leo, J Urbain, C R Maliszewski, M Moser.   

Abstract

Data from adoptive transfer of mature dendritic cells (DC) indicate that they are responsible for the induction of primary immunity. Two subclasses of DC have been recently identified in spleen that differ in their phenotype and in certain regulatory features. In vitro, both subsets have the capacity to activate naive T cells, although CD8a+ DC have been shown to induce T cell apoptosis and to stimulate lower levels of cytokines compared with CD8alpha- DC. The objective of this study was to analyze the function of these distinct DC types in vivo. Our results show that both subsets, pulsed extracorporeally with antigen and injected in the footpads of syngeneic mice, sensitize an antigen-specific T cell primary response. However, CD8alpha+ cells trigger the development of Thl-type cells, whereas CD8alpha- DC induce a Th2-type response. These observations suggest that the Th1/Th2 balance in vivo is regulated by the antigen-presenting-cells of the primary immune responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449161     DOI: 10.1002/jlb.66.2.242

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  40 in total

1.  Induction of polyomavirus-specific CD8(+) T lymphocytes by distinct dendritic cell subpopulations.

Authors:  D R Drake; M L Shawver; A Hadley; E Butz; C Maliszewski; A E Lukacher
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy.

Authors:  Ulrike Kämmerer; Andreas O Eggert; Michaela Kapp; Alexander D McLellan; Teunis B H Geijtenbeek; Johannes Dietl; Yvette van Kooyk; Eckhart Kämpgen
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

3.  Both exogenous and endogenous interleukin-10 affects the maturation of bone-marrow-derived dendritic cells in vitro and strongly influences T-cell priming in vivo.

Authors:  Claus Haase; Trine N Jørgensen; Birgitte K Michelsen
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

4.  Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo.

Authors:  Claus Haase; Mette Ejrnaes; Amy E Juedes; Tom Wolfe; Helle Markholst; Matthias G von Herrath
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

Review 5.  Immunological decision-making: how does the immune system decide to mount a helper T-cell response?

Authors:  Gerard E Kaiko; Jay C Horvat; Kenneth W Beagley; Philip M Hansbro
Journal:  Immunology       Date:  2007-11-05       Impact factor: 7.397

6.  Antigen processing and CD24 expression determine antigen presentation by splenic CD4+ and CD8+ dendritic cells.

Authors:  David Askew; Clifford V Harding
Journal:  Immunology       Date:  2007-10-19       Impact factor: 7.397

7.  CD103+ lung dendritic cells (LDCs) induce stronger Th1/Th17 immunity to a bacterial lung infection than CD11bhi LDCs.

Authors:  Sudhanshu Shekhar; Ying Peng; Shuhe Wang; Xi Yang
Journal:  Cell Mol Immunol       Date:  2017-02-13       Impact factor: 11.530

8.  GM-CSF-induced CD11c+CD8a--dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis.

Authors:  Balaji B Ganesh; Donald M Cheatem; Jian Rong Sheng; Chenthamarakshan Vasu; Bellur S Prabhakar
Journal:  Int Immunol       Date:  2009-01-27       Impact factor: 4.823

9.  The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement.

Authors:  Irina Caminschi; Anna I Proietto; Fatma Ahmet; Susie Kitsoulis; Joo Shin Teh; Jennifer C Y Lo; Alexandra Rizzitelli; Li Wu; David Vremec; Serani L H van Dommelen; Ian K Campbell; Eugene Maraskovsky; Hal Braley; Gayle M Davey; Patricia Mottram; Nicholas van de Velde; Kent Jensen; Andrew M Lew; Mark D Wright; William R Heath; Ken Shortman; Mireille H Lahoud
Journal:  Blood       Date:  2008-07-30       Impact factor: 22.113

10.  Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis.

Authors:  Matthew N Meriggioli; Jian Rong Sheng; Liangcheng Li; Bellur S Prabhakar
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.